Sen. John Fetterman’s Hospitalization From ‘Lightheadedness’ Wasn’t Another Stroke
FRIDAY, Feb. 10, 2023 (HealtDay News) — Sen. John Fetterman, who suffered a stroke last May while campaigning for his Senate seat, remains hospitalized after being admitted on Wednesday for lightheadedness, but doctors have ruled out a second stroke….
Learn MoreUpdated Booster Shots, Not Original COVID Vaccines, Should Be Standard: FDA Panel
THURSDAY, Jan. 26, 2023 (HealthDay News) — The U.S. Food and Drug Administration’s vaccine advisory panel on Thursday voted unanimously to recommend that the agency phase out original versions of COVID vaccines for use in the unvaccinated, in favor o…
Learn MoreU.S. Proposes to Make COVID Shot Annual, Much Like Flu Shot
MONDAY, Jan. 23, 2023 (HealthDay News) — The U.S. Food and Drug Administration on Monday asked its vaccine advisory panel to weigh a proposal to turn COVID vaccines into an annual shot for most Americans.Such a move would simplify future vaccination …
Learn MoreAnother Major HIV Vaccine Trial Fails
THURSDAY, Jan. 19, 2023 (HealthDay News) — In yet another setback for the future of HIV prevention, the only HIV vaccine in a late-stage trial has failed, study leaders announced Wednesday.Launched in 2019 as a partnership between the U.S. government…
Learn MoreDamar Hamlin Released From Buffalo Hospital As Recovery From Cardiac Arrest Continues
WEDNESDAY, Jan. 11, 2023 (HealthDay News) — Buffalo Bills safety Damar Hamlin has been released from a Buffalo hospital just nine days after he suffered cardiac arrest during a Monday night football game. “Damar Hamlin has been discharged from Buffal…
Learn MoreCongressional Report Slams FDA, Drugmaker Over Approval of Alzheimer’s Drug Aduhelm
THURSDAY, Dec. 29, 2022 (HealthDay News) — The U.S. Food and Drug Administration’s approval process for the controversial Alzheimer’s drug Aduhelm was “rife with irregularities,” despite lingering doubts about the power of the pricey medication to sl…
Learn MoreExperimental Alzheimer’s Drug May Slow Decline, But Safety Concerns Linger
WEDNESDAY, Nov. 30, 2022 (HealthDay News) — The experimental Alzheimer’s drug lecanemab slowed thinking declines among patients suffering the early stages of the disease in a new study, but safety concerns about brain swelling and brain bleeds remain…
Learn MorePfizer’s New Booster Shot Shows Protection Against Emerging Omicron Variants
FRIDAY, Nov. 18, 2022 (HealthDay News) — Pfizer’s updated COVID booster shots are proving their mettle against emerging omicron variants, the company announced Friday.The latest version of the vaccine generated virus-fighting antibodies against four …
Learn MoreCalifornia Voters Ban Flavored Tobacco, and a Cigarette Maker Is Suing
FRIDAY, Nov. 11, 2022 (HealthDay News) — Only one day after California voters approved allowing a state law banning flavored tobacco products to take effect, a tobacco giant has sued to prevent it. R.J. Reynolds on Wednesday filed a federal lawsuit c…
Learn MoreBiden Administration Announces National Plan to End Hunger By 2030
TUESDAY, Sept. 27, 2022 (HealthDay News) — The White House on Tuesday released a national plan to end hunger by 2030, an ambitious goal that would be accomplished largely by expanding monthly food benefits for poor Americans.The plan would also aim t…
Learn More